-
EMA approves Moderna COVID-19 Vaccine
08 January, 2021
EMA approves COVID-19 Vaccine Moderna following review of safety and efficacy data...COVID-19
-
NHS critically ill patients to receive tocilizumab and sarilumab, reducing time spent in ICU by 10 days
United Kingdom // 07 January, 2021
COVID-19 patients in ICU to receive potentially life-saving treatments...COVID-19
-
Sinovac vaccine 78% effective in a trial in Brazil
Brazil // 07 January, 2021
One step closer to regulatory approval...COVID-19
-
CureVac joins Bayer to help with COVID-19 vaccine distribution
07 January, 2021
CureVac will benefit from Bayer's established infrastructure...COVID-19
-
COVID-19 vaccination to begin in February 2021
Colombia // 07 January, 2021
Officials have confirmed that Pfizer will supply 10 million doses of COVID-19 vaccine progressively in 2021...COVID-19
-
Study: COVID-19 transmission on a flight to New Zealand
New Zealand // 07 January, 2021
Seven cases of COVID-19 were confirmed in passengers who flew to Auckland in September...COVID-19
-
Study: convalescent plasma can have positive effect if given early
07 January, 2021
A small study in Argentina showed older adults....COVID-19
-
Allergic reaction to Pfizer vaccine
United States // 06 January, 2021
Several people have been treated for a severe allergic reaction following vaccination...COVID-19
-
Warning that mutant strain may spread rapidly in Denmark
Denmark // 06 January, 2021
Warning for infection control to stop spread of mutant virus.COVID-19
-
Study estimates 14% of Americans had COVID-19 by mid-November
United States // 06 January, 2021
A modelling study has estimated that almost 47 million Americans ...COVID-19
-
South African 501Y.V2 variant probably still susceptible to vaccine-induced immunity
05 January, 2021
A new study on the effect of variant viruses on antibodies shows...COVID-19
-
Moderna vaccine approved in Israel
Israel // 05 January, 2021
Israel has approved Moderna vaccine...COVID-19
-
India bans export of AstraZeneca vaccine
India // 05 January, 2021
India Today reports the Serum Institute of India (SII) CEO, Adar Poonawalla, as saying that India has barred the vaccine maker from exporting the Oxford University-AstraZeneca coronavirus vaccine for several months...
COVID-19
-
Having had COVID-19 protects healthcare workers for at least six months
05 January, 2021
A journal has published results of a study in Newcastle, UK...COVID-19
-
Study to determine if vaccine reduces or prevents transmission cancelled
05 January, 2021
A seminal study designed to determine whether and to what extent...COVID-19
-
What do the English COVID-19 intervention tiers mean?
United Kingdom // 05 January, 2021
A Tier 4 “Stay at Home” alert was issued for...COVID-19
-
Which vaccines can be “quickly” modified for a new variant?
05 January, 2021
Reuters reports that “…an advantage of mRNA vaccine technology is that scientists can quickly re-engineer genetic material in the shot to match that of the mutated protein, whereas modifying traditional vaccines would require...COVID-19
-
What does “Pandemic Level 5” in the UK mean?
United Kingdom // 05 January, 2021
Media reports that the UK's coronavirus alert level is...COVID-19
-
B.1.1.7 variant has a higher reproduction number
05 January, 2021
As England and Scotland move into Tier 4 lock-downs...COVID-19
-
COVID-19 vaccination has begun
Monaco // 05 January, 2021
COVID-19 vaccination is underway...COVID-19